Parkinson's disease severity levels and MDS-Unified Parkinson's Disease Rating Scale
Abstract Background Severity of PD is usually assessed by means of the motor and disability-based Hoehn and Yahr staging (HY), or clinician and patient global perceptions. Scores of more detailed assessments, as the MDS-UPDRS, have not been translated to a grading that allows assignment of score sec...
Gespeichert in:
Veröffentlicht in: | Parkinsonism & related disorders 2015-01, Vol.21 (1), p.50-54 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 54 |
---|---|
container_issue | 1 |
container_start_page | 50 |
container_title | Parkinsonism & related disorders |
container_volume | 21 |
creator | Martínez-Martín, Pablo Rodríguez-Blázquez, Carmen Mario Alvarez Arakaki, Tomoko Arillo, Víctor Campos Chaná, Pedro Fernández, William Garretto, Nélida Martínez-Castrillo, Juan Carlos Rodríguez-Violante, Mayela Serrano-Dueñas, Marcos Ballesteros, Diego Rojo-Abuin, Jose Manuel Chaudhuri, Kallol Ray Merello, Marcelo |
description | Abstract Background Severity of PD is usually assessed by means of the motor and disability-based Hoehn and Yahr staging (HY), or clinician and patient global perceptions. Scores of more detailed assessments, as the MDS-UPDRS, have not been translated to a grading that allows assignment of score sections to severity levels. The objective of the present study is to determine cut-off points for PD severity levels based on the MDS-UPDRS. Methods International, observational study. Applied assessments were: HY, MDS-UPDRS, Clinical Impression for Severity Index, and Clinical and Patient Global Impression of Severity. The coincidence in severity level (mild, moderate, severe) of at least two clinical classifications plus the patient's gradation was considered “the criterion of severity”. Cut-off values for each MDS-UPDRS subscale was determined by triangulation of: 1) percentile 90 of the subscale total score; 2) receiver operating characteristic (ROC) analysis; and 3) ordinal logistic regression (OLR) model. Results Sample was composed of 452 consecutive PD patients without dementia, 55.3% males, age 65.1 ± 10.7 years and PD duration 8.7 ± 6.3 years. All HY stages were represented. The “criterion”, classified 275 patients (60.8% of the sample) as: mild PD, 149 (54.2%); moderate, 82 (29.8%); and severe, 44 (16%). The following MDS-UPDRS cut-off points between mild/moderate and moderate/severe levels were found: Part 1: 10/11 and 21/22; Part 2: 12/13 and 29/30; Part 3: 32/33 and 58/59; and Part 4: 4/5 and 12/13. Conclusion Cut-off points to classify PD patients as mild, moderate, or severe on the basis of their MDS-UPDRS scores are proposed. |
doi_str_mv | 10.1016/j.parkreldis.2014.10.026 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1668271579</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S1353802014004118</els_id><sourcerecordid>1668271579</sourcerecordid><originalsourceid>FETCH-LOGICAL-c512t-2ecb083a38d5b2d04b190905f65745fdb4f069889673f29cf5f4a524340dd0173</originalsourceid><addsrcrecordid>eNqNkk9v1DAQxSMEoqXwFVBucMl2_DfOBQnaQiu1KmLbs-XYY-Rt1lnsbKX99jjaBSpOPXnkee_N6KepqprAggCRp6vFxqSHhIMLeUGB8PK9ACpfVMdEtawRhMqXpWaCNQooHFVvcl4BQCuAva6OqOBScpDH1d33EhRiHuOHXJc0NBnrjI-YwrSrh1IMuTbR1Tfny-Y-Bh_Q1U895wfPDzOF-LNeWjPg2-qVN0PGd4f3pLr_enF3dtlc3367Ovt83diy4NRQtD0oZphyoqcOeE866EB4KVouvOu5B9kp1cmWedpZLzw3gnLGwTkgLTupPu5zN2n8tcU86XXIFofBRBy3WRMpFW2JaLtnSFnXzeJZqvZSm8acE3q9SWFt0k4T0DN-vdL_8OsZ_9wp-Iv1_WHKtl-j-2v8w7sIvuwFBSs-Bkw624DRogsJ7aTdGJ4z5dN_IXYIMRTyD7jDvBq3KRbsmuhMNejlfAbzFRAOwAlR7Dd0mK6v</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1639982719</pqid></control><display><type>article</type><title>Parkinson's disease severity levels and MDS-Unified Parkinson's Disease Rating Scale</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Martínez-Martín, Pablo ; Rodríguez-Blázquez, Carmen ; Mario Alvarez ; Arakaki, Tomoko ; Arillo, Víctor Campos ; Chaná, Pedro ; Fernández, William ; Garretto, Nélida ; Martínez-Castrillo, Juan Carlos ; Rodríguez-Violante, Mayela ; Serrano-Dueñas, Marcos ; Ballesteros, Diego ; Rojo-Abuin, Jose Manuel ; Chaudhuri, Kallol Ray ; Merello, Marcelo</creator><creatorcontrib>Martínez-Martín, Pablo ; Rodríguez-Blázquez, Carmen ; Mario Alvarez ; Arakaki, Tomoko ; Arillo, Víctor Campos ; Chaná, Pedro ; Fernández, William ; Garretto, Nélida ; Martínez-Castrillo, Juan Carlos ; Rodríguez-Violante, Mayela ; Serrano-Dueñas, Marcos ; Ballesteros, Diego ; Rojo-Abuin, Jose Manuel ; Chaudhuri, Kallol Ray ; Merello, Marcelo</creatorcontrib><description>Abstract Background Severity of PD is usually assessed by means of the motor and disability-based Hoehn and Yahr staging (HY), or clinician and patient global perceptions. Scores of more detailed assessments, as the MDS-UPDRS, have not been translated to a grading that allows assignment of score sections to severity levels. The objective of the present study is to determine cut-off points for PD severity levels based on the MDS-UPDRS. Methods International, observational study. Applied assessments were: HY, MDS-UPDRS, Clinical Impression for Severity Index, and Clinical and Patient Global Impression of Severity. The coincidence in severity level (mild, moderate, severe) of at least two clinical classifications plus the patient's gradation was considered “the criterion of severity”. Cut-off values for each MDS-UPDRS subscale was determined by triangulation of: 1) percentile 90 of the subscale total score; 2) receiver operating characteristic (ROC) analysis; and 3) ordinal logistic regression (OLR) model. Results Sample was composed of 452 consecutive PD patients without dementia, 55.3% males, age 65.1 ± 10.7 years and PD duration 8.7 ± 6.3 years. All HY stages were represented. The “criterion”, classified 275 patients (60.8% of the sample) as: mild PD, 149 (54.2%); moderate, 82 (29.8%); and severe, 44 (16%). The following MDS-UPDRS cut-off points between mild/moderate and moderate/severe levels were found: Part 1: 10/11 and 21/22; Part 2: 12/13 and 29/30; Part 3: 32/33 and 58/59; and Part 4: 4/5 and 12/13. Conclusion Cut-off points to classify PD patients as mild, moderate, or severe on the basis of their MDS-UPDRS scores are proposed.</description><identifier>ISSN: 1353-8020</identifier><identifier>EISSN: 1873-5126</identifier><identifier>DOI: 10.1016/j.parkreldis.2014.10.026</identifier><identifier>PMID: 25466406</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Adolescent ; Adult ; Aged ; Aged, 80 and over ; Assessment ; Cross-Sectional Studies ; Disability Evaluation ; Female ; Humans ; International Cooperation ; Male ; MDS-UPDRS ; Middle Aged ; Neurology ; Observation ; Parkinson Disease - diagnosis ; Parkinson Disease - physiopathology ; Parkinson's disease ; Severity ; Severity of Illness Index ; Staging ; Young Adult</subject><ispartof>Parkinsonism & related disorders, 2015-01, Vol.21 (1), p.50-54</ispartof><rights>Elsevier Ltd</rights><rights>2014 Elsevier Ltd</rights><rights>Copyright © 2014 Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c512t-2ecb083a38d5b2d04b190905f65745fdb4f069889673f29cf5f4a524340dd0173</citedby><cites>FETCH-LOGICAL-c512t-2ecb083a38d5b2d04b190905f65745fdb4f069889673f29cf5f4a524340dd0173</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.parkreldis.2014.10.026$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3548,27923,27924,45994</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25466406$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Martínez-Martín, Pablo</creatorcontrib><creatorcontrib>Rodríguez-Blázquez, Carmen</creatorcontrib><creatorcontrib>Mario Alvarez</creatorcontrib><creatorcontrib>Arakaki, Tomoko</creatorcontrib><creatorcontrib>Arillo, Víctor Campos</creatorcontrib><creatorcontrib>Chaná, Pedro</creatorcontrib><creatorcontrib>Fernández, William</creatorcontrib><creatorcontrib>Garretto, Nélida</creatorcontrib><creatorcontrib>Martínez-Castrillo, Juan Carlos</creatorcontrib><creatorcontrib>Rodríguez-Violante, Mayela</creatorcontrib><creatorcontrib>Serrano-Dueñas, Marcos</creatorcontrib><creatorcontrib>Ballesteros, Diego</creatorcontrib><creatorcontrib>Rojo-Abuin, Jose Manuel</creatorcontrib><creatorcontrib>Chaudhuri, Kallol Ray</creatorcontrib><creatorcontrib>Merello, Marcelo</creatorcontrib><title>Parkinson's disease severity levels and MDS-Unified Parkinson's Disease Rating Scale</title><title>Parkinsonism & related disorders</title><addtitle>Parkinsonism Relat Disord</addtitle><description>Abstract Background Severity of PD is usually assessed by means of the motor and disability-based Hoehn and Yahr staging (HY), or clinician and patient global perceptions. Scores of more detailed assessments, as the MDS-UPDRS, have not been translated to a grading that allows assignment of score sections to severity levels. The objective of the present study is to determine cut-off points for PD severity levels based on the MDS-UPDRS. Methods International, observational study. Applied assessments were: HY, MDS-UPDRS, Clinical Impression for Severity Index, and Clinical and Patient Global Impression of Severity. The coincidence in severity level (mild, moderate, severe) of at least two clinical classifications plus the patient's gradation was considered “the criterion of severity”. Cut-off values for each MDS-UPDRS subscale was determined by triangulation of: 1) percentile 90 of the subscale total score; 2) receiver operating characteristic (ROC) analysis; and 3) ordinal logistic regression (OLR) model. Results Sample was composed of 452 consecutive PD patients without dementia, 55.3% males, age 65.1 ± 10.7 years and PD duration 8.7 ± 6.3 years. All HY stages were represented. The “criterion”, classified 275 patients (60.8% of the sample) as: mild PD, 149 (54.2%); moderate, 82 (29.8%); and severe, 44 (16%). The following MDS-UPDRS cut-off points between mild/moderate and moderate/severe levels were found: Part 1: 10/11 and 21/22; Part 2: 12/13 and 29/30; Part 3: 32/33 and 58/59; and Part 4: 4/5 and 12/13. Conclusion Cut-off points to classify PD patients as mild, moderate, or severe on the basis of their MDS-UPDRS scores are proposed.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Assessment</subject><subject>Cross-Sectional Studies</subject><subject>Disability Evaluation</subject><subject>Female</subject><subject>Humans</subject><subject>International Cooperation</subject><subject>Male</subject><subject>MDS-UPDRS</subject><subject>Middle Aged</subject><subject>Neurology</subject><subject>Observation</subject><subject>Parkinson Disease - diagnosis</subject><subject>Parkinson Disease - physiopathology</subject><subject>Parkinson's disease</subject><subject>Severity</subject><subject>Severity of Illness Index</subject><subject>Staging</subject><subject>Young Adult</subject><issn>1353-8020</issn><issn>1873-5126</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkk9v1DAQxSMEoqXwFVBucMl2_DfOBQnaQiu1KmLbs-XYY-Rt1lnsbKX99jjaBSpOPXnkee_N6KepqprAggCRp6vFxqSHhIMLeUGB8PK9ACpfVMdEtawRhMqXpWaCNQooHFVvcl4BQCuAva6OqOBScpDH1d33EhRiHuOHXJc0NBnrjI-YwrSrh1IMuTbR1Tfny-Y-Bh_Q1U895wfPDzOF-LNeWjPg2-qVN0PGd4f3pLr_enF3dtlc3367Ovt83diy4NRQtD0oZphyoqcOeE866EB4KVouvOu5B9kp1cmWedpZLzw3gnLGwTkgLTupPu5zN2n8tcU86XXIFofBRBy3WRMpFW2JaLtnSFnXzeJZqvZSm8acE3q9SWFt0k4T0DN-vdL_8OsZ_9wp-Iv1_WHKtl-j-2v8w7sIvuwFBSs-Bkw624DRogsJ7aTdGJ4z5dN_IXYIMRTyD7jDvBq3KRbsmuhMNejlfAbzFRAOwAlR7Dd0mK6v</recordid><startdate>20150101</startdate><enddate>20150101</enddate><creator>Martínez-Martín, Pablo</creator><creator>Rodríguez-Blázquez, Carmen</creator><creator>Mario Alvarez</creator><creator>Arakaki, Tomoko</creator><creator>Arillo, Víctor Campos</creator><creator>Chaná, Pedro</creator><creator>Fernández, William</creator><creator>Garretto, Nélida</creator><creator>Martínez-Castrillo, Juan Carlos</creator><creator>Rodríguez-Violante, Mayela</creator><creator>Serrano-Dueñas, Marcos</creator><creator>Ballesteros, Diego</creator><creator>Rojo-Abuin, Jose Manuel</creator><creator>Chaudhuri, Kallol Ray</creator><creator>Merello, Marcelo</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7TK</scope></search><sort><creationdate>20150101</creationdate><title>Parkinson's disease severity levels and MDS-Unified Parkinson's Disease Rating Scale</title><author>Martínez-Martín, Pablo ; Rodríguez-Blázquez, Carmen ; Mario Alvarez ; Arakaki, Tomoko ; Arillo, Víctor Campos ; Chaná, Pedro ; Fernández, William ; Garretto, Nélida ; Martínez-Castrillo, Juan Carlos ; Rodríguez-Violante, Mayela ; Serrano-Dueñas, Marcos ; Ballesteros, Diego ; Rojo-Abuin, Jose Manuel ; Chaudhuri, Kallol Ray ; Merello, Marcelo</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c512t-2ecb083a38d5b2d04b190905f65745fdb4f069889673f29cf5f4a524340dd0173</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Assessment</topic><topic>Cross-Sectional Studies</topic><topic>Disability Evaluation</topic><topic>Female</topic><topic>Humans</topic><topic>International Cooperation</topic><topic>Male</topic><topic>MDS-UPDRS</topic><topic>Middle Aged</topic><topic>Neurology</topic><topic>Observation</topic><topic>Parkinson Disease - diagnosis</topic><topic>Parkinson Disease - physiopathology</topic><topic>Parkinson's disease</topic><topic>Severity</topic><topic>Severity of Illness Index</topic><topic>Staging</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Martínez-Martín, Pablo</creatorcontrib><creatorcontrib>Rodríguez-Blázquez, Carmen</creatorcontrib><creatorcontrib>Mario Alvarez</creatorcontrib><creatorcontrib>Arakaki, Tomoko</creatorcontrib><creatorcontrib>Arillo, Víctor Campos</creatorcontrib><creatorcontrib>Chaná, Pedro</creatorcontrib><creatorcontrib>Fernández, William</creatorcontrib><creatorcontrib>Garretto, Nélida</creatorcontrib><creatorcontrib>Martínez-Castrillo, Juan Carlos</creatorcontrib><creatorcontrib>Rodríguez-Violante, Mayela</creatorcontrib><creatorcontrib>Serrano-Dueñas, Marcos</creatorcontrib><creatorcontrib>Ballesteros, Diego</creatorcontrib><creatorcontrib>Rojo-Abuin, Jose Manuel</creatorcontrib><creatorcontrib>Chaudhuri, Kallol Ray</creatorcontrib><creatorcontrib>Merello, Marcelo</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Neurosciences Abstracts</collection><jtitle>Parkinsonism & related disorders</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Martínez-Martín, Pablo</au><au>Rodríguez-Blázquez, Carmen</au><au>Mario Alvarez</au><au>Arakaki, Tomoko</au><au>Arillo, Víctor Campos</au><au>Chaná, Pedro</au><au>Fernández, William</au><au>Garretto, Nélida</au><au>Martínez-Castrillo, Juan Carlos</au><au>Rodríguez-Violante, Mayela</au><au>Serrano-Dueñas, Marcos</au><au>Ballesteros, Diego</au><au>Rojo-Abuin, Jose Manuel</au><au>Chaudhuri, Kallol Ray</au><au>Merello, Marcelo</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Parkinson's disease severity levels and MDS-Unified Parkinson's Disease Rating Scale</atitle><jtitle>Parkinsonism & related disorders</jtitle><addtitle>Parkinsonism Relat Disord</addtitle><date>2015-01-01</date><risdate>2015</risdate><volume>21</volume><issue>1</issue><spage>50</spage><epage>54</epage><pages>50-54</pages><issn>1353-8020</issn><eissn>1873-5126</eissn><abstract>Abstract Background Severity of PD is usually assessed by means of the motor and disability-based Hoehn and Yahr staging (HY), or clinician and patient global perceptions. Scores of more detailed assessments, as the MDS-UPDRS, have not been translated to a grading that allows assignment of score sections to severity levels. The objective of the present study is to determine cut-off points for PD severity levels based on the MDS-UPDRS. Methods International, observational study. Applied assessments were: HY, MDS-UPDRS, Clinical Impression for Severity Index, and Clinical and Patient Global Impression of Severity. The coincidence in severity level (mild, moderate, severe) of at least two clinical classifications plus the patient's gradation was considered “the criterion of severity”. Cut-off values for each MDS-UPDRS subscale was determined by triangulation of: 1) percentile 90 of the subscale total score; 2) receiver operating characteristic (ROC) analysis; and 3) ordinal logistic regression (OLR) model. Results Sample was composed of 452 consecutive PD patients without dementia, 55.3% males, age 65.1 ± 10.7 years and PD duration 8.7 ± 6.3 years. All HY stages were represented. The “criterion”, classified 275 patients (60.8% of the sample) as: mild PD, 149 (54.2%); moderate, 82 (29.8%); and severe, 44 (16%). The following MDS-UPDRS cut-off points between mild/moderate and moderate/severe levels were found: Part 1: 10/11 and 21/22; Part 2: 12/13 and 29/30; Part 3: 32/33 and 58/59; and Part 4: 4/5 and 12/13. Conclusion Cut-off points to classify PD patients as mild, moderate, or severe on the basis of their MDS-UPDRS scores are proposed.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>25466406</pmid><doi>10.1016/j.parkreldis.2014.10.026</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1353-8020 |
ispartof | Parkinsonism & related disorders, 2015-01, Vol.21 (1), p.50-54 |
issn | 1353-8020 1873-5126 |
language | eng |
recordid | cdi_proquest_miscellaneous_1668271579 |
source | MEDLINE; ScienceDirect Journals (5 years ago - present) |
subjects | Adolescent Adult Aged Aged, 80 and over Assessment Cross-Sectional Studies Disability Evaluation Female Humans International Cooperation Male MDS-UPDRS Middle Aged Neurology Observation Parkinson Disease - diagnosis Parkinson Disease - physiopathology Parkinson's disease Severity Severity of Illness Index Staging Young Adult |
title | Parkinson's disease severity levels and MDS-Unified Parkinson's Disease Rating Scale |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T14%3A49%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Parkinson's%20disease%20severity%20levels%20and%20MDS-Unified%20Parkinson's%20Disease%20Rating%20Scale&rft.jtitle=Parkinsonism%20&%20related%20disorders&rft.au=Mart%C3%ADnez-Mart%C3%ADn,%20Pablo&rft.date=2015-01-01&rft.volume=21&rft.issue=1&rft.spage=50&rft.epage=54&rft.pages=50-54&rft.issn=1353-8020&rft.eissn=1873-5126&rft_id=info:doi/10.1016/j.parkreldis.2014.10.026&rft_dat=%3Cproquest_cross%3E1668271579%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1639982719&rft_id=info:pmid/25466406&rft_els_id=1_s2_0_S1353802014004118&rfr_iscdi=true |